Trametinib
Back to searchMolecule Structure
Scientific Name
Trametinib
Description of the Drug
Trametinib is a kinase inhibitor used to treat patients with specific types of melanoma, non-small cell lung cancer, and thyroid cancer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08911
http://www.drugbank.ca/drugs/DB08911
Brand Name(s)
Mekinist
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Dual specificity mitogen-activated protein kinase kinase; MEK1/2 | PROTEIN FAMILY | INHIBITOR | CHEMBL2111289 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL170938 | |
| PharmGKB | PA166115364 | |
| DrugBank | DB08911 | |
| PubChem: Thomson Pharma | 117699169 | |
| PubChem | 11707110 | |
| LINCS | LSM-1143 | |
| Nikkaji | J3.135.455B | |
| PDBe | QOM | |
| BindingDB | 50531540 | |
| DrugCentral | 4802 | |
| Brenda | 217794 | 217806 |
| ChemicalBook | CB32514557 | |
| Guide to Pharmacology | 6495 | |
| rxnorm | TRAMETINIB | |
| ChEBI | 75998 | |
| ZINC | ZINC000043100709 |
